It can arise from tumor biology (e.g., kallikrein–kinin system activation and inflammatory cytokines) or treatment-related factors (e.g., chemotherapy, surgery, and radiation; refs. 23, 27–30). The gene discussed is KLK4; the disease is neoplasm.